{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:42:06Z","timestamp":1788550926246,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.pnpbp.2021.110332","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T05:55:48Z","timestamp":1618984548000},"page":"110332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Prolactin, metabolic and immune parameters in na\u00efve subjects with a first episode of psychosis"],"prefix":"10.1016","volume":"110","author":[{"given":"Clemente","family":"Garc\u00eda-Rizo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"V\u00e1zquez-Bourgon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Labad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Ortiz Garc\u00eda de la Foz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"G\u00f3mez-Revuelta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Juncal Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicto","family":"Crespo-Facorro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2021.110332_bb0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1472-6823-13-12","article-title":"Serum prolactin concentrations as risk factor of metabolic syndrome or type 2 diabetes?","volume":"13","author":"Balbach","year":"2013","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0010","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.12659\/MSM.909970","article-title":"Lack of relationships between serum prolactin concentrations and classical cardiovascular risk factors in eastern Croatian older adults","volume":"24","author":"Beki\u0107","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing - when and how?","author":"Bender","year":"2001","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0020","doi-asserted-by":"crossref","first-page":"10779","DOI":"10.1073\/pnas.1708025114","article-title":"Prolactin action in the medial preoptic area is necessary for postpartum maternal nursing behavior","volume":"114","author":"Brown","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0025","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-017-1346-x","article-title":"Prolactin function and putative expression in the brain","author":"Cabrera-Reyes","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.pnpbp.2021.110332_bb0030","doi-asserted-by":"crossref","DOI":"10.1111\/cen.12204","article-title":"Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels","author":"Ciresi","year":"2013","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2014.11.005","article-title":"Prolactin: a versatile regulator of inflammation and autoimmune pathology","author":"Costanza","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychires.2006.05.002","article-title":"Predictors of acute treatment response in patients with a first episode of non-affective psychosis: Sociodemographics, premorbid and clinical variables","author":"Crespo-Facorro","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.psyneuen.2017.09.020","article-title":"Plasma lipoproteins in posttraumatic stress disorder patients compared to healthy controls and their associations with the HPA- and HPT-axis","volume":"86","author":"de Vries","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2021.110332_bb0050","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.psychres.2019.03.027","article-title":"Prolactin levels in drug-na\u00efve first episode nonaffective psychosis patients compared with healthy controls. Sex differences","volume":"276","author":"Del Cacho","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0055","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00737-018-0899-x","article-title":"Plasma prolactin levels are associated with the severity of illness in drug-naive first-episode psychosis female patients","volume":"22","author":"Delgado-Alvarado","year":"2019","journal-title":"Arch. Womens. Ment. Health"},{"key":"10.1016\/j.pnpbp.2021.110332_bb0060","article-title":"Predictive value of prolactin in first episode psychosis at ten years follow-up","author":"Delgado-Alvarado","year":"2020","journal-title":"Rev. Psiquiatr. Salud Ment."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10911-016-9369-0","article-title":"Role of prolactin in promotion of immune cell migration into the mammary gland","volume":"22","author":"Dill","year":"2017","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.pnpbp.2021.110332_bb0070","article-title":"BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists","author":"Dos Santos Silva","year":"2011","journal-title":"Obesity"},{"key":"10.1016\/j.pnpbp.2021.110332_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2015.08.013","article-title":"Men and women differ in inflammatory and neuroendocrine responses to endotoxin but not in the severity of sickness symptoms","author":"Engler","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.pnpbp.2021.110332_bb1075","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0080","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2265.2011.04075.x","article-title":"The association of serum prolactin concentration with inflammatory biomarkers - cross-sectional findings from the population-based study of health in Pomerania","volume":"75","author":"Friedrich","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0085","doi-asserted-by":"crossref","first-page":"109910","DOI":"10.1016\/j.pnpbp.2020.109910","article-title":"Implications of early life stress on fetal metabolic programming of schizophrenia: a focus on epiphenomena underlying morbidity and early mortality","volume":"101","author":"Garcia-Rizo","year":"2020","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110332_bb0090","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.schres.2011.07.025","article-title":"Prolactin concentrations in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis","volume":"134","author":"Garcia-Rizo","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2016.02.001","article-title":"Abnormal glycemic homeostasis at the onset of serious mental illnesses: a common pathway","volume":"67","author":"Garcia-Rizo","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2021.110332_bb0100","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/humrep\/deu133","article-title":"Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome","volume":"29","author":"Glintborg","year":"2014","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2016.03.018","article-title":"Prolactin concentrations in antipsychotic-na\u00efve patients with schizophrenia and related disorders: a meta-analysis","author":"Gonz\u00e1lez-Blanco","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0110","first-page":"85","article-title":"The prolactin receptor: diverse and emerging roles in pathophysiology","volume":"2","author":"Gorvin","year":"2015","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.50","article-title":"Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity","volume":"6","author":"Gragnoli","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110332_bb0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0306-4530(02)00112-9","article-title":"Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects","volume":"28","author":"Halbreich","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2021.110332_bb0125","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/eurheartj\/ehs233","article-title":"Positive association of serum prolactin concentrations with all-cause and cardiovascular mortality","volume":"35","author":"Haring","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0130","article-title":"Association between biomarkers of low-grade inflammation and sex hormones in women with polycystic ovary syndrome","author":"Hatziagelaki","year":"2019","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.pnpbp.2021.110332_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2018.11.028","article-title":"The role of cortisol and prolactin in the pathogenesis and clinical expression of psychotic disorders","author":"Labad","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2021.110332_bb0145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jpsychires.2014.10.011","article-title":"Stress biomarkers as predictors of transition to psychosis in at-risk mental states: roles for cortisol, prolactin and albumin","volume":"60","author":"Labad","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0150","doi-asserted-by":"crossref","DOI":"10.3371\/CSRP.MICU.020813","article-title":"C-reactive protein levels in schizophrenia: a review and meta-analysis","author":"Miller","year":"2014","journal-title":"Clin. Schizophr. Relat. Psychoses."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0155","first-page":"9","article-title":"Increased prolactin levels are associated with impaired processing speed in subjects with early psychosis","author":"Montalvo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2021.110332_bb0165","doi-asserted-by":"crossref","first-page":"R720","DOI":"10.1152\/ajpregu.00282.2013","article-title":"Prolactin promotes normal liver growth, survival, and regeneration in rodents: effects on hepatic IL-6, suppressor of cytokine signaling-3, and angiogenesis","volume":"305","author":"Moreno-Carranza","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0170","doi-asserted-by":"crossref","first-page":"R902","DOI":"10.1152\/ajpregu.00003.2018","article-title":"Prolactin regulates liver growth during postnatal development in mice","volume":"314","author":"Moreno-Carranza","year":"2018","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055176","article-title":"Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden","volume":"8","author":"Nordentoft","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2021.110332_bb0180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1530\/JOE-18-0518","article-title":"Pancreatic prolactin receptor signaling regulates maternal glucose homeostasis","volume":"241","author":"Nteeba","year":"2019","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0185","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.lfs.2015.10.016","article-title":"Short-term hyperprolactinemia decreases allergic inflammatory response of the lungs","volume":"142","author":"Ochoa-Amaya","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0190","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.scog.2015.10.004","article-title":"The search for new biomarkers for cognition in schizophrenia","volume":"2","author":"Penad\u00e9s","year":"2015","journal-title":"Schizophr. Res. Cogn."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/S2215-0366(16)30379-0","article-title":"Oestrogens, prolactin, hypothalamic-pituitary-gonadal axis, and schizophrenic psychoses","author":"Riecher-R\u00f6ssler","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110332_bb0200","first-page":"56","article-title":"Prolactin promotes adipose tissue fitness and insulin sensitivity in obese males","volume":"158","author":"Ruiz-Herrera","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.pnpbp.2021.110332_bb0205","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11011-016-9882-2","article-title":"Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas","volume":"32","author":"Schwetz","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0210","doi-asserted-by":"crossref","DOI":"10.1111\/j.1460-9568.2011.07788.x","article-title":"Endogenous prolactin generated during peripheral inflammation contributes to thermal hyperalgesia","author":"Scotland","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0215","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2265.2006.02469.x","article-title":"The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy","volume":"64","author":"Serri","year":"2006","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2018.03.048","article-title":"Ablation of prolactin receptor increases hepatic triglyceride accumulation","author":"Shao","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00720","article-title":"Insight into the endocrine system and the immune system: a review of the inflammatory role of prolactin in rheumatoid arthritis and psoriatic arthritis","author":"Tang","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2016.00025","article-title":"Actions of prolactin in the brain: from physiological adaptations to stress and neurogenesis to psychopathology","author":"Torner","year":"2016","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.pnpbp.2021.110332_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40261-019-00854-w","article-title":"Targeting hormones for improving cognition in major mood disorders and schizophrenia: thyroid hormones and prolactin","volume":"40","author":"Tost","year":"2020","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0240","series-title":"Prolactin Disorders: From Basic Science to Clinical Management","author":"Tritos","year":"2019"},{"key":"10.1016\/j.pnpbp.2021.110332_bb0245","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1507\/endocrj.52.89","article-title":"Subclinical hypothyroidism may be associated with elevated high-sensitive C-reactive protein (low grade inflammation) and fasting hyperinsulinemia","volume":"52","author":"Tuzcu","year":"2005","journal-title":"Endocr. J."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0250","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1139\/jpn.0837","article-title":"Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: a review of the evidence and putative mechanisms","volume":"33","author":"Van Lieshout","year":"2008","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0255","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1161\/ATVBAHA.110.209569","article-title":"Prolactin and venous thrombosis: indications for a novel risk factor?","volume":"31","author":"Van Zaane","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.pnpbp.2021.110332_bb0260","doi-asserted-by":"crossref","first-page":"109677","DOI":"10.1016\/j.pnpbp.2019.109677","article-title":"Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients","volume":"95","author":"V\u00e1zquez-Bourgon","year":"2019","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110332_bb0265","article-title":"Clinical relevance of serum prolactin levels to inflammatory reaction in male patients","author":"Yamamoto","year":"2020","journal-title":"Acta Med. Okayama"},{"key":"10.1016\/j.pnpbp.2021.110332_bb0270","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-019-1120-z","article-title":"A newly noninvasive model for prediction of non-alcoholic fatty liver disease: utility of serum prolactin levels","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Gastroenterol."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584621000919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584621000919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:58:55Z","timestamp":1759521535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584621000919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":53,"alternative-id":["S0278584621000919"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110332","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prolactin, metabolic and immune parameters in na\u00efve subjects with a first episode of psychosis","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110332"}}